Mountain View, CA, United States of America

Wenge Zhang

This inventor holds 2 USPTO granted patents. Top assignee: Abbott Biotherapeutics Corp.. Active years: 2011-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenge Zhang. Retrieved from https://idiyas.com/inventor/wenge-zhang-1xpym1hi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Wenge Zhang: Innovator in Immunoglobulin Display Vectors

Introduction

Wenge Zhang is a notable inventor based in Mountain View, CA. He has made significant contributions to the field of biotherapeutics, particularly in the development of immunoglobulin display vectors. With a total of 2 patents, his work has the potential to impact various therapeutic applications.

Latest Patents

Wenge Zhang's latest patents focus on immunoglobulin display vectors. These patents disclose mammalian expression vectors that enable the simultaneous expression of immunoglobulins in both secreted and cell surface-bound forms. This innovation could enhance the efficiency of therapeutic antibody production.

Career Highlights

Wenge Zhang is currently associated with Abbott Biotherapeutics Corporation, where he continues to advance his research in biotherapeutics. His expertise in immunoglobulin technology positions him as a key player in the field.

Collaborations

Wenge has collaborated with notable colleagues, including Robert B. Dubridge and Susan Rhodes. Their combined efforts contribute to the innovative research environment at Abbott Biotherapeutics Corporation.

Conclusion

Wenge Zhang's contributions to immunoglobulin display vectors exemplify the importance of innovation in biotherapeutics. His work not only advances scientific understanding but also holds promise for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…